SCHEMBL4972095

SCHEMBL4972095

CC(C)(C)OC(=O)N1Cc2cc(NC(=O)c3cccnc3F)cnc2C(C)(C)C1.CC1(C)CCCNc2cc(NC(=O)c3cccnc3F)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CIT O14578 1/20 0.37
MAP3K7 O43318 1/20 0.37
RIPK2 O43353 1/20 0.37
STK10 O94804 1/20 0.37
MAP4K4 O95819 1/20 0.37
ABL1 P00519 1/20 0.37
EGFR P00533 1/20 0.37
RAF1 P04049 1/20 0.37
LCK P06239 1/20 0.37
FYN P06241 1/20 0.37
CSF1R P07333 1/20 0.37
YES1 P07947 1/20 0.37
LYN P07948 1/20 0.37
RET P07949 1/20 0.37
HCK P08631 1/20 0.37
PDGFRB P09619 1/20 0.37
FGR P09769 1/20 0.37
KIT P10721 1/20 0.37
FGFR1 P11362 1/20 0.37
BRAF P15056 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5426130 0.88 NR1H2 (0.43) RAF1BRAFKDRNR1H2MAPT
SCHEMBL445073 0.83 NR1H2 (0.41) CITMAP3K7RIPK2STK10MAP4K4
SCHEMBL5421091 0.81 CIT (0.52) CITMAP3K7RIPK2STK10MAP4K4
SCHEMBL4092040 0.76 ABL1 (0.55) CITMAP3K7RIPK2STK10MAP4K4
SCHEMBL4975909 0.73 VCP (0.43) CITMAP3K7RIPK2STK10MAP4K4
SCHEMBL3818526 0.73 POLB (0.50) KDRNR1H2MAPTLMNARAB9A
SCHEMBL6105662 0.71 KDR (0.51) CITMAP3K7RIPK2STK10MAP4K4
SCHEMBL3155809 0.71 KDR (0.44) CITMAP3K7RIPK2STK10MAP4K4
SCHEMBL449101 0.71 LCLAT1 (0.40) CITMAP3K7RIPK2STK10MAP4K4
SCHEMBL4978601 0.71 ABL1 (0.52) CITMAP3K7RIPK2STK10MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971604-B1 PYRROLO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES AMGEN INC (US) 2012-08-01 EP disclosed
EP-1971604-A2 PYRROLO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES Amgen Inc. (US) 2008-09-24 EP disclosed
WO-2007048070-A2 PYRROLO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES AMGEN INC. (US) 2007-04-26 WO disclosed